Primary central nervous system lymphoma

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 11, 2008, Pages 1830-1834

  Bhagavathi, Sharathkumar ^a   Wilson, Jon D ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; METHOTREXATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAPLASTIC CARCINOMA; ARTICLE; ATAXIA TELANGIECTASIA; AUTOIMMUNE DISEASE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHROMOSOME ANALYSIS; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG MEGADOSE; EYE DISEASE; GLIOMA; HEADACHE; HUMAN; IATROGENIC DISEASE; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFARCTION; INTRACRANIAL PRESSURE; LARGE CELL LYMPHOMA; LOW GRADE LYMPHOMA; LYMPHOMA; MENINGEAL CYST; METASTASIS; MICROSCOPY; MYASTHENIA GRAVIS; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; ONSET AGE; PATHOGENESIS; PERSONALITY DISORDER; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY INTRAOCULAR LYMPHOMA; PROGNOSIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SEIZURE; SEX RATIO; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LYMPHOMA; TREATMENT RESPONSE; TUMOR LOCALIZATION; VASCULITIS; WISKOTT ALDRICH SYNDROME;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; PROGNOSIS;

EID: 55549096004     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.1043/1543-2165-132.11.1830     Document Type: Article

References (24)

1. Central Brain Tumor Registry of the United States. Primary Brain Tumors in The United States 1995-1999: Statistical Report. Chicago, Ill: Central Brain Tumor Registry of the United States; 2002-2003.
2. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press; 2000. World Health Organization Classification of Tumors.
3. Aubrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23:5034-5043.
4. Aubrey LE, Ben-Porat L, Panageas KS, et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering cancer center prognostic model. J Clin Oncol. 2006;24:5711-5715.
5. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol. 1999;43:199-201.
6. Camilleri-Broet S, Martin A, Moreau A, et al. Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Am J Clin Pathol. 1998;110:607-611.
7. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993;119:1093-1104.
8. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000;92:261-266.
9. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression and germinal center formation by BCL-6. Science. 1997;276:589-592.
10. Braaten KM, Betensky RA, de Level L, et al. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res. 2003;9:1063-1069.
11. Lin CH, Kuo KT, Chuang SS, et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous origin and peripheral nodal origin. Clin Cancer Res. 2006;12:1152-1156.
12. Camilleri-Broet S, Criniere E, Broet P, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood. 2005;1007:190-196.
13. Rubenstein JL, Fridlyand J, Shen A, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006;1007:3716-3723.
14. Kady FM, Law ME, Porter-Umphrey AB, et al. The frequency of specific chromosomal abnormalities in primary central system lymphomas (PCNSL) differs from systemic diffuse large B-cell lymphoma (DLBCL), suggesting a distinct pathogenesis. Poster presented at: United States and Canadian Academy of Pathology; March 24-30, 2007; San Diego, Calif.
15. Nakamura M, Shimada K, Konishi N. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas. Histol Histopathol. 2004;19:211-219.
16. Rubenstein JL, Treseler P, O'Brien JM. Pathology and genetics of primary central nervous system and intraocular lymphoma. Hematol Oncol Clin North Am. 2005;19:705-717.
17. Miller DC, Hochberg FH, Harris NL, et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma: the Massachusetts General Hospital experience 1958-1989. Cancer. 1994;74:1383-1397.
18. Chamberlain MC. Long survival in patients with acquired immune deficiency syndrome related primary central nervous system lymphoma. Cancer. 1994;73:1728-1730.
19. Ferreri AJ, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002;58:1513-1520.
20. Shenkier TN, Blay JY, O'Neill BP, et al. Primary CNS lymphoma of T cell origin: a descriptive analysis from the international Primary CNS Lymphoma Collaborative Group. J Clin Oncol. 2005;23:2233-2239.
21. Rupani A, Modi C, Desai S, Rege J. Primary large cell anaplastic cell lymphoma of central nervous system-a case report. J Postgrad Med. 2006;51:326-327.
22. George DH, Scheithauer BW, Aker FV, et al. Primary anaplastic large cell lymphoma of the central nervous system: Prognostic effect of ALK-1 expression. Am J Surg Pathol. 2003;27:487-493.
23. Jahnke K, Korfel A, O'Neill BP, et al. International study on low-grade primary central nervous system lymphoma. Ann Neurol. 2006;59:755-762.
24. Klein R, Mullges W, Bendszus M, Woydt M, Kreipe H, Roggendorf W. Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of literature. Am J Surg Pathol. 1999;23:477-481.